Table 1 Patient characteristics

Age (yrs; mean ± SD)

72.2 ± 2.7

61.3 ± 13.1

Sex

 Men

5

2

 Women

1

1

Cause of disease

 Hepatitis B

0

1

 Hepatitis C

6

2

BCLC stage

 B

4

1

 C

2

2

Previous therapy

 Surgery

1

0

 TAE/TACE/RFA

4

2

 None

1

1

Tumor size (mm; mean ± SD)

 Baseline

30.7 ± 22.1

33.5 ± 14.1

 1 week

30.3 ± 21.8

35.0 ± 14.6

 2 weeks

31.0 ± 20.7

37.3 ± 16.7

 4 weeks

31.5 ± 19.4

38.5 ± 15.9

Treatment

 Sorafenib (initial dose)

200 mg twice daily

200 mg twice daily